2 results
Approved WMORecruiting
Evaluation of the effect of treatment with the Meniett in patients with unstable Menière*s disease.
Approved WMOCompleted
To evaluate the dose response relationship of LNP023 on the reduction in proteinuria versus placebo after 90 days of treatment in patients with IgA nephropathy.